|
⚲
|
| Keyboard |
| Kastelein Johannes Jacob Pieter
✚
|
|
|---|---|
| CIK # | 0002000389 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0002000389] | |
| 4 | [0002000389] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| NewAmsterdam Pharma Co NV | |
| Kastelein Johannes Jacob Pieter |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
NewAmsterdam Pharma Co NV NAMS
Option (right to buy) · derivative
|
2026-03-09 | Option exercise | 101,409 | $0.00 | |
|
NewAmsterdam Pharma Co NV NAMS
Ordinary Shares
|
2026-03-09 | Option exercise | 101,409 | ||
|
NewAmsterdam Pharma Co NV NAMS
Ordinary Shares
|
2026-03-09 | Sell | 101,409 | $30.29 | 3,071,679 |
|
NewAmsterdam Pharma Co NV NAMS
Ordinary Shares
|
2026-03-06 | Sell | 94,124 | $30.32 | 2,853,840 |
|
NewAmsterdam Pharma Co NV NAMS
Ordinary Shares
|
2026-03-06 | Option exercise | 94,124 | ||
|
NewAmsterdam Pharma Co NV NAMS
Option (right to buy) · derivative
|
2026-03-06 | Option exercise | 94,124 | $0.00 | |
|
NewAmsterdam Pharma Co NV NAMS
Ordinary Shares
|
2026-03-05 | Sell | 104,467 | $30.30 | 3,165,350 |
|
NewAmsterdam Pharma Co NV NAMS
Option (right to buy) · derivative
|
2026-03-05 | Option exercise | 104,467 | $0.00 | |
|
NewAmsterdam Pharma Co NV NAMS
Ordinary Shares
|
2026-03-05 | Option exercise | 104,467 | ||
|
NewAmsterdam Pharma Co NV NAMS
Ordinary Shares
|
2026-02-20 | Sell | 14,692 | $35.00 | 514,220 |
|
NewAmsterdam Pharma Co NV NAMS
Ordinary Shares
|
2026-02-20 | Sell | 30,789 | $35.46 | 1,091,778 |
|
NewAmsterdam Pharma Co NV NAMS
Option (right to buy) · derivative
|
2026-01-07 | Grant | 115,000 | $0.00 | |
|
NewAmsterdam Pharma Co NV NAMS
Ordinary Shares
|
2026-01-07 | Grant | 25,500 | ||
|
NewAmsterdam Pharma Co NV NAMS
Ordinary Shares
|
2026-01-05 | Sell | 6,000 | $33.25 | 199,500 |
|
NewAmsterdam Pharma Co NV NAMS
Restricted Stock Unit · derivative
|
2025-03-26 | Option exercise | 45,481 | ||
|
NewAmsterdam Pharma Co NV NAMS
Restricted Stock Unit · derivative
|
2025-03-26 | Grant | 45,481 | ||
|
NewAmsterdam Pharma Co NV NAMS
Ordinary Shares
|
2025-03-26 | Grant | 19,302 | $0.00 | |
|
NewAmsterdam Pharma Co NV NAMS
Ordinary Shares
|
2025-03-26 | Option exercise | 45,481 | $0.00 | |
|
NewAmsterdam Pharma Co NV NAMS
Ordinary Shares
|
2025-03-24 | Option exercise | 150,000 | ||
|
NewAmsterdam Pharma Co NV NAMS
Option (right to buy) · derivative
|
2025-03-24 | Option exercise | 150,000 | $0.00 | |
| showing 20 of 27 most recent transactions | |||||